A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical trial NCT04660539 · COMPLETED
Trial details
- NCT number
- NCT04660539
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2024-05-28
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.